Nasdaq futures are implying a down -46 points start for the US stocks. The S&P is targeting down -23 points and the Dow is looking to be down -20 modest points.
Despite the declines some consistant gainers continue their gains in pre-market trading.
- Moderna (MRNA) — +7.82%
Shares spiked after the biotech company announced it had already been developing a hantavirus vaccine ahead of the outbreak aboard the cruise ship Hondius. A timely catalyst in a volatile macro environment. - Intel (INTC) — +4.8%
Intel gained after the Wall Street Journal reported the chipmaker had reached a preliminary agreement with Apple to manufacture some of the chips used in Apple devices. A major credibility boost for Intel’s struggling foundry ambitions. - Micron (MU) — +6.25% (premarket)
Micron shares continue to rise, driven by a global memory chip shortage and soaring demand for AI accelerators and inference hardware. Since late March, Micron shares have more than doubled, and analysts foresee a possible supercycle in chipmaking extending beyond next year. - Nebius (NBIS) — Edging higher
Nebius edged higher ahead of its Q1 2026 earnings report, having recently hit an all-time high. The company has partnered with Nvidia in a $2 billion deal to build a full-stack AI cloud and plans to acquire Eigen AI for $643 million, with agreements also in place with Meta and Microsoft.
As the new trading week begins, yields are higher with the 2 year up 1.7 basis points at 3.909% and the 10 year is up 1.4 basis points at 4.380%.
Oil is higher with the price up $1.20 at $96.69.
